title: A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.
abstract: BACKGROUND
  Randomized trials have largely failed to support an effect of antioxidant vitamins on the risk of cardiovascular disease (CVD). Few trials have examined interactions among antioxidants, and, to our knowledge, no previous trial has examined the individual effect of ascorbic acid (vitamin C) on CVD.
  
  
  METHODS
  The Women's Antioxidant Cardiovascular Study tested the effects of ascorbic acid (500 mg/d), vitamin E (600 IU every other day), and beta carotene (50 mg every other day) on the combined outcome of myocardial infarction, stroke, coronary revascularization, or CVD death among 8171 female health professionals at increased risk in a 2 x 2 x 2 factorial design. Participants were 40 years or older with a history of CVD or 3 or more CVD risk factors and were followed up for a mean duration of 9.4 years, from 1995-1996 to 2005.
  
  
  RESULTS
  A total of 1450 women experienced 1 or more CVD outcomes. There was no overall effect of ascorbic acid (relative risk [RR], 1.02; 95% CI, 0.92-1.13 [P = .71]), vitamin E (RR, 0.94; 95% CI, 0.85-1.04 [P = .23]), or beta carotene (RR, 1.02; 95% CI, 0.92-1.13 [P = .71]) on the primary combined end point or on the individual secondary outcomes of myocardial infarction, stroke, coronary revascularization, or CVD death. A marginally significant reduction in the primary outcome with active vitamin E was observed among the prespecified subgroup of women with prior CVD (RR, 0.89; 95% CI, 0.79-1.00 [P = .04]; P value for interaction, .07). There were no significant interactions between agents for the primary end point, but those randomized to both active ascorbic acid and vitamin E experienced fewer strokes (P value for interaction, .03).
  
  
  CONCLUSIONS
  There were no overall effects of ascorbic acid, vitamin E, or beta carotene on cardiovascular events among women at high risk for CVD.
authors: Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215, USA. ncook@rics.bwh.harvard.edu
authors: Nancy R
authors: NR
authors: Cook
authors: Christine M
authors: CM
authors: Albert
authors: J Michael
authors: JM
authors: Gaziano
authors: Elaine
authors: E
authors: Zaharris
authors: Jean
authors: J
authors: MacFadyen
authors: Eleanor
authors: E
authors: Danielson
authors: Julie E
authors: JE
authors: Buring
authors: JoAnn E
authors: JE
authors: Manson
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D014810:Vitamin E / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*; D019207:beta Carotene / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D014815:Vitamins; D019207:beta Carotene; D014810:Vitamin E; D001205:Ascorbic Acid
references: N Engl J Med. 1997 Aug 7;337(6):408-16
references: 9241131
references: J Nutr. 2006 Oct;136(10):2588-93
references: 16988131
references: Arch Intern Med. 2004 Nov 22;164(21):2335-42
references: 15557412
references: N Engl J Med. 1993 May 20;328(20):1450-6
references: 8479464
references: JAMA. 2007 Feb 28;297(8):842-57
references: 17327526
references: JAMA. 1996 Mar 6;275(9):699-703
references: 8594267
references: N Engl J Med. 1996 May 2;334(18):1150-5
references: 8602180
references: Lancet. 1999 Aug 7;354(9177):447-55
references: 10465168
references: JAMA. 2005 Mar 16;293(11):1338-47
references: 15769967
references: N Engl J Med. 1994 Apr 14;330(15):1029-35
references: 8127329
references: Nutr Rev. 2005 Aug;63(8):290-3
references: 16190316
references: J Natl Cancer Inst. 1999 Dec 15;91(24):2102-6
references: 10601381
references: J Natl Cancer Inst. 1993 Sep 15;85(18):1483-92
references: 8360931
references: N Engl J Med. 1989 Apr 6;320(14):915-24
references: 2648148
references: Am J Clin Nutr. 2005 Oct;82(4):879-86
references: 16210720
references: Lancet. 2000 Oct 7;356(9237):1213-8
references: 11072938
references: N Engl J Med. 1993 May 20;328(20):1444-9
references: 8479463
references: N Engl J Med. 2000 Jan 20;342(3):154-60
references: 10639540
references: Lancet. 1996 Mar 23;347(9004):781-6
references: 8622332
references: Lancet. 1997 Jun 14;349(9067):1715-20
references: 9193380
references: Lancet. 1994 Sep 10;344(8924):721-4
references: 7915779
references: Am J Clin Nutr. 1996 Aug;64(2):190-6
references: 8694019
references: JAMA. 2002 Nov 20;288(19):2432-40
references: 12435256
references: Lancet. 2001 Jan 13;357(9250):89-95
references: 11197445
references: Am J Epidemiol. 1998 Jan 15;147(2):180-6
references: 9457009
references: J Womens Health (Larchmt). 2004 Jan-Feb;13(1):99-117
references: 15006283
references: Circulation. 2003 Feb 25;107(7):947-53
references: 12600905
references: Stroke. 2004 Jul;35(7):1584-8
references: 15178820
references: N Engl J Med. 1996 May 2;334(18):1156-62
references: 8602181
references: N Engl J Med. 2006 Feb 16;354(7):669-83
references: 16481635
references: Circulation. 2003 Aug 19;108(7):802-7
references: 12900344
references: JAMA. 2005 Jul 6;294(1):56-65
references: 15998891
references: N Engl J Med. 1996 May 2;334(18):1145-9
references: 8602179
references: N Engl J Med. 2001 Nov 29;345(22):1583-92
references: 11757504
references: Ann Intern Med. 2005 Jan 4;142(1):37-46
references: 15537682
references: Curr Opin Lipidol. 2005 Feb;16(1):47-54
references: 15650563